BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34630524)

  • 1. Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
    Yu J; Liang LL; Liu J; Liu TT; Li J; Xiu L; Zeng J; Wang TT; Wang D; Liang LJ; Xie DW; Chen DX; An JS; Wu LY
    Front Genet; 2021; 12():733715. PubMed ID: 34630524
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
    Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY
    Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer.
    Song L; Wang S; Li Q; Lu Y; Yang R; Feng X
    J Oncol; 2023; 2023():9931419. PubMed ID: 36936373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Wang X; Wang J; Yu M
    Comput Math Methods Med; 2022; 2022():1902289. PubMed ID: 35345518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes.
    Yang J; Wei X; Hu F; Dong W; Sun L
    Cancer Cell Int; 2022 Jan; 22(1):21. PubMed ID: 35033072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructe a novel 5 hypoxia genes signature for cervical cancer.
    Yang Y; Li Y; Qi R; Zhang L
    Cancer Cell Int; 2021 Jul; 21(1):345. PubMed ID: 34217310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
    Ma Y; Yang J; Ji T; Wen F
    Front Genet; 2022; 13():990623. PubMed ID: 36246622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma.
    Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H
    Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma.
    Xu P; Liu S; Song S; Yao X; Li X; Zhang J; Liu Y; Zheng Y; Gao G; Xu J
    Front Oncol; 2022; 12():965102. PubMed ID: 36727080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
    Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
    Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer.
    Liang L; Li J; Yu J; Liu J; Xiu L; Zeng J; Wang T; Li N; Wu L
    Cancer Cell Int; 2022 Mar; 22(1):118. PubMed ID: 35292033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
    Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
    Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer.
    Liu X; Wang D; Han S; Wang F; Zang J; Xu C; Dong X
    J Oncol; 2022; 2022():7467797. PubMed ID: 35211172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
    Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
    Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer.
    Wang L; Gao S
    Biol Res; 2021 Jun; 54(1):18. PubMed ID: 34187591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer.
    Yu J; Yao HW; Liu TT; Wang D; Shi JH; Yuan GW; Ma S; Wu LY
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.